Over the past 12 months, 5 insiders at Fulcrum Therapeutics, Inc. filed 13 open-market SEC Form 4 transactions on FULC: 4 purchases worth $891K and 9 sales worth $59.2M. Insiders have been net sellers over this period. The most recent filing was on Jul 15, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 15, 26 | Kevin Tang10% Owner | BUY | 107.4K | $3.56 | $382K |
| Jul 14, 26 | Kevin Tang10% Owner | BUY | 76.0K | $3.58 | $272K |
| Jul 13, 26 | Kevin Tang10% Owner | BUY | 13.0K | $3.54 | $46K |
| Jun 26, 26 | Alan Ezekowitz | SELL | 18.0K | $3.65 | $66K |
| Feb 2, 26 | Robert J GouldDirector | SELL | 15.0K | $10.72 | $161K |
| Jan 2, 26 | Robert J GouldDirector | SELL | 15.0K | $11.87 | $178K |
| Dec 15, 25 | Curtis Gale OltmansChief Legal Officer | SELL | 3.5K | $12.92 | $45K |
| Dec 8, 25 | Ra Capital Healthcare Fund LpTenPercentOwner | SELL | 2.71M | $14.98 | $38.6M |
| Nov 19, 25 | Robert J GouldDirector | SELL | 15.0K | $11.03 | $165K |
| May 8, 25 | Greg TourangeauPrincipal Accounting Officer | SELL | 498 | $5.06 | $3K |
| May 7, 24 | Greg TourangeauPrincipal Accounting Officer | SELL | 236 | $7.76 | $2K |
| Mar 8, 24 | Greg TourangeauVice President, Finance | SELL | 4.9K | $11.72 | $57K |
| Mar 4, 24 | Alex SapirSee Remarks | BUY | 43.4K | $11.35 | $492K |
| May 10, 23 | Greg TourangeauPrincipal Accounting Officer | SELL | 210 | $3.31 | $695 |
| Jan 20, 23 | Ra Capital Management, L.p.TenPercentOwner | BUY | 1.92M | $13.00 | $25.0M |
| Jan 13, 23 | Robert J GouldInterim President & CEO | SELL | 6.8K | $15.00 | $101K |
| Jan 4, 23 | Ra Capital Healthcare Fund LpTenPercentOwner | BUY | 122.3K | $7.80 | $860K |
| Dec 27, 22 | Peter KolchinskyTenPercentOwner | BUY | 4.1K | $5.99 | $24K |
| Dec 19, 22 | Peter KolchinskyTenPercentOwner | BUY | 98.8K | $5.90 | $583K |
| Dec 16, 22 | Ra Capital Management, L.p.TenPercentOwner | BUY | 1.34M | $5.42 | $7.3M |
| Dec 15, 22 | Ra Capital Management, L.p.TenPercentOwner | BUY | 237.0K | $5.50 | $1.3M |
| Dec 14, 22 | Ra Capital Management, L.p.TenPercentOwner | BUY | 824.6K | $5.46 | $4.5M |
| Jun 7, 22 | Robert J GouldDirector | SELL | 71.4K | $8.09 | $578K |
| Jun 6, 22 | Robert J GouldDirector | SELL | 24.4K | $8.10 | $197K |
| Jun 3, 22 | Robert J GouldDirector | SELL | 25.6K | $7.95 | $203K |
| Jun 2, 22 | Robert J GouldDirector | SELL | 16.7K | $7.92 | $132K |
| Apr 7, 22 | Robert J GouldDirector | SELL | 5.6K | $24.02 | $135K |
| Apr 5, 22 | Robert J GouldDirector | SELL | 52.6K | $24.26 | $1.3M |
| Apr 4, 22 | Robert J GouldDirector | SELL | 7.2K | $24.02 | $174K |
| Apr 1, 22 | Robert J GouldDirector | SELL | 34.5K | $24.03 | $828K |
| Aug 11, 21 | Bryan StuartSee Remarks | SELL | 28.0K | $23.75 | $665K |
| Aug 10, 21 | Christopher MoxhamChief Scientific Officer | SELL | 31.1K | $18.00 | $559K |
| Aug 10, 21 | Bryan StuartSee Remarks | SELL | 32.0K | $17.50 | $560K |
Over the past 12 months, insiders at Fulcrum Therapeutics, Inc. filed 4 open-market purchases worth $891K and 9 sales worth $59.2M on FULC, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 15, 26.
The largest recent open-market FULC insider purchase in our data was $25.0M by Ra Capital Management, L.p., TenPercentOwner, filed on Jan 20, 23.
5 different insiders at Fulcrum Therapeutics, Inc. filed open-market SEC Form 4 transactions on FULC over the last 12 months.
InsiderTape plots every FULC insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Fulcrum Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →